Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lam C Tsoi

Showing results (81-90 of 245) with videos related to

Pageof 25
Sort By:
JCI Insight|August 9, 2022
Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trialDinesh Khanna, Cristina Padilla, Lam C Tsoi, et al.
American Journal of Human Genetics|June 25, 2019
TIGAR: An Improved Bayesian Tool for Transcriptomic Data Imputation Enhances Gene Mapping of Complex TraitsSini Nagpal, Xiaoran Meng, Michael P Epstein, et al.
Frontiers in Immunology|February 14, 2018
RNA-Seq Analysis of IL-1B and IL-36 Responses in Epidermal Keratinocytes Identifies a Shared MyD88-Dependent Gene SignatureWilliam R Swindell, Maria A Beamer, Mrinal K Sarkar, et al.
Annals of the Rheumatic Diseases|May 15, 2017
A rare coding allele in <i>IFIH1</i> is protective for psoriatic arthritisAshley Budu-Aggrey, John Bowes, Philip E Stuart, et al.
JCI Insight|March 15, 2022
Single-cell transcriptomics reveals distinct effector profiles of infiltrating T cells in lupus skin and kidneyGarrett S Dunlap, Allison C Billi, Xianying Xing, et al.
The Journal of Investigative Dermatology|August 24, 2025
Endothelin-2 from keratinocytes and Its Association with Itch in Skin DiseasesYumeng Dong, Mrinal K Sarkar, Yuntian Wu, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Keratin 16 spatially inhibits type I interferon responses in stressed skinErez Cohen, Yang Xu, Amanda Orosco, et al.
Nature Communications|December 11, 2025
A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumabAndrew Blauvelt, Rundong Jiang, Linyu Shi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 11, 2020
Comparison of Lesional Juvenile Myositis and Lupus Skin Reveals Overlapping Yet Unique Disease PathophysiologyJessica L Turnier, Lauren M Pachman, Lori Lowe, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Multiomic Analysis Reveals an IFN-driven Cellular Landscape Effectively Targeted by Ruxolitinib in Hailey-Hailey DiseaseSara Ceccacci, Hoang Duc Minh Pham, Marion Dessaignes, et al.
Pageof 25

Showing results (81-90 of 245) with videos related to

Sort By:
Pageof 25
JCI Insight|August 9, 2022
Tofacitinib blocks IFN-regulated biomarker genes in skin fibroblasts and keratinocytes in a systemic sclerosis trialDinesh Khanna, Cristina Padilla, Lam C Tsoi, et al.
American Journal of Human Genetics|June 25, 2019
TIGAR: An Improved Bayesian Tool for Transcriptomic Data Imputation Enhances Gene Mapping of Complex TraitsSini Nagpal, Xiaoran Meng, Michael P Epstein, et al.
Frontiers in Immunology|February 14, 2018
RNA-Seq Analysis of IL-1B and IL-36 Responses in Epidermal Keratinocytes Identifies a Shared MyD88-Dependent Gene SignatureWilliam R Swindell, Maria A Beamer, Mrinal K Sarkar, et al.
Annals of the Rheumatic Diseases|May 15, 2017
A rare coding allele in <i>IFIH1</i> is protective for psoriatic arthritisAshley Budu-Aggrey, John Bowes, Philip E Stuart, et al.
JCI Insight|March 15, 2022
Single-cell transcriptomics reveals distinct effector profiles of infiltrating T cells in lupus skin and kidneyGarrett S Dunlap, Allison C Billi, Xianying Xing, et al.
The Journal of Investigative Dermatology|August 24, 2025
Endothelin-2 from keratinocytes and Its Association with Itch in Skin DiseasesYumeng Dong, Mrinal K Sarkar, Yuntian Wu, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Keratin 16 spatially inhibits type I interferon responses in stressed skinErez Cohen, Yang Xu, Amanda Orosco, et al.
Nature Communications|December 11, 2025
A randomized phase 2 clinical trial to treat moderate-to-severe plaque psoriasis patients with high-induction dosing of risankizumabAndrew Blauvelt, Rundong Jiang, Linyu Shi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 11, 2020
Comparison of Lesional Juvenile Myositis and Lupus Skin Reveals Overlapping Yet Unique Disease PathophysiologyJessica L Turnier, Lauren M Pachman, Lori Lowe, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Multiomic Analysis Reveals an IFN-driven Cellular Landscape Effectively Targeted by Ruxolitinib in Hailey-Hailey DiseaseSara Ceccacci, Hoang Duc Minh Pham, Marion Dessaignes, et al.
Pageof 25